Jubilant Pharmova Limited
Bandhan Mutual Fund increased its stake in Jubilant Pharmova from 2.36% to 4.01%. The fund purchased 26,21,267 shares, raising its total holding to 63,87,723 shares.
An integrated global pharmaceuticals company, Jubilant Pharmova operates across three core business segments: pharmaceuticals, contract research and development services, and proprietary novel drugs. The company serves domestic and international markets through its diversified portfolio and specialized capabilities in drug development and manufacturing. It combines vertically integrated operations with expertise in custom synthesis and advanced pharmaceutical formulations to address healthcare needs across multiple therapeutic areas.
Formerly IDFC Mutual Fund, rebranded after Bandhan Financial Holdings acquired IDFC's AMC in 2023. Manages over Rs 1.5 lakh crore. Known for strong debt and liquid funds, plus well-regarded equity offerings including the IDFC-lineage Sterling Value Fund and Focused Equity Fund. One of the cleaner transitions in Indian AMC ownership history.